Biomarker Research in Neuromuscular Diseases
A special issue of Neurology International (ISSN 2035-8377). This special issue belongs to the section "Movement Disorders and Neurodegenerative Diseases".
Deadline for manuscript submissions: closed (30 November 2025) | Viewed by 1447
Special Issue Editor
Special Issue Information
Dear Colleagues,
Neuromuscular diseases include a wide range of diseases of the peripheral nervous system, including the diseases of muscles, nerves and lower motor neurons.
In recent years, significant progress has been made in this field, both in diagnostic and therapeutic possibilities. There is a need for easy-to-use clinical and biochemical biomarkers to monitor disease severity, as well as to follow disease progression and for prognostic purposes.
In this Special Issue, we aim to cover a broad spectrum of diseases including, but not limited to, the following:
- Spinal muscular atrophy;
- Polyneuropathies with a diverse etiology;
- Small-fiber neuropathy;
- Autoimmune myositis;
- Muscular dystrophies;
- Myopathies either of hereditary or acquired origin.
In muscular dystrophies, recent publications focused on the degradation sarcomeric proteins (troponin, titin) and their correlations with clinical scores. However, we do not have widely accepted fluid biomarkers for muscle atrophy and sarcopenia. In contrast, the determination of levels of neurofilaments in serum or CSF seems more frequently used in peripheral nerve damage.
In summary, we expect publications either of new research studies or overviews of clinical and biochemical investigations related to already used or new biomarkers in neuromuscular disorders.
Dr. Endre Pál
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Neurology International is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomarkers
- microRNA
- myopathy
- muscular dystrophy
- neurofilament
- polyneuropathy
- small-fiber neuropathy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
